CytoMed Therapeutics is focused on translating its technologies into innate immune cell-based “off-the-shelf” products for a wide range of cancers.We also engage in generating induced pluripotent stem cells (iPSCs) and translating them into “off-the-shelf” cellular therapeutics using our proprietary technologies for our customers.
CytoMed Therapeutics is focused on translating its technologies into innate immune cell-based “off-the-shelf” products for a wide range of cancers.We also engage in generating induced pluripotent stem cells (iPSCs) and translating them into “off-the-shelf” cellular therapeutics using our proprietary technologies for our customers.
CytoMed Therapeutics is focused on translating its technologies into innate immune cell-based “off-the-shelf” products for a wide range of cancers.We also engage in generating induced pluripotent stem cells (iPSCs) and translating them into “off-the-shelf” cellular therapeutics using our proprietary technologies for our customers.